Home |
List of Drugs | Attorney
|
Site-Map |
Links |
Contact-Us
Lamisil Lawsuits
|
|
Lamisil is
a medication for the treatment of onychomycosis, or fungus of the nail. The
FDA issued a public health advisory warning physicians of the link between Lamisil and hepatic adverse events. The Lamisil risks include liver failure
that can lead to death or liver transplant. Manufacturer Novartis
Pharmaceuticals revised the labeling for Lamisil in the Warnings,
Precautions, and Adverse Reactions sections.
The FDA received 16 reports of liver failure cases in Lamisil patients as of
April 2001. In addition, prescribing errors have occurred instead of
prescribing Lamisil patients have received
Lamictal,
an anti-epileptic.